Active Ingredient: SELEGILINE HYDROCHLORIDE
Proprietary Name: ZELAPAR
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 1.25MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021479
Product Number: 001
Approval Date: Jun 14, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
